文献速递肺外科

淋巴结比率可预测不同分期非小细胞肺癌患者的生存:一项多中心分析

Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该多中心回顾性分析纳入2002年1月至2012年12月6家机构4858例接受解剖性肺切除及肺门纵隔淋巴结清扫的非小细胞肺癌患者,评估淋巴结比率(NR)等预后因素与总生存(OS)和无病生存(DFS)的关系。多因素分析显示年龄、性别、病理分期、R0切除、手术方式和NR与较长OS相关,NR<40%与更高的5年生存率显著相关。

要点

  • 淋巴结比率(NR)<40%与全样本更高的5年OS(57.6% vs 23.8%,P<0.001)和DFS(48.2% vs 11.4%,P<0.001)显著相关。
  • N1患者中NR<40%与更高5年OS(47.9% vs 36.1%,P=0.03)和DFS(39% vs 24.2%,P=0.02)显著相关。
  • N2患者中NR<40%与更高5年OS(36.9% vs 21.8%,P<0.001)和DFS(23.9% vs 9.1%,P<0.001)显著相关。

核心结论

  • 研究证实清扫淋巴结数量是非小细胞肺癌的强预后指标,淋巴结比率(NR)截断值40%可能预测OS和DFS。

研究设计与样本

  • 多中心回顾性分析,纳入2002年1月至2012年12月6家机构4858例接受解剖性肺切除及肺门纵隔淋巴结清扫的非小细胞肺癌患者。

主要发现

  • 清扫淋巴结数量中位数为17枚(范围6-85),转移淋巴结数量中位数为2枚(范围1-36)。
  • 肺门(N1)和纵隔(N2)转移分别占21.3%和20.0%。
  • 总体5年OS和DFS分别为54.6%和44.8%。
  • 多因素分析中年龄、性别、病理分期、R0切除、手术方式和NR与较长OS相关,上述变量加肿瘤分级与DFS相关。
  • C统计量DFS为66.0(95%CI 62.7-69.4),OS为60.5(95%CI 58.3-62.6)。

关键数值与推荐

  • NR<40%与全样本更高5年OS(57.6% vs 23.8%,P<0.001)和DFS(48.2% vs 11.4%,P<0.001)显著相关。
  • N1患者中NR<40%与更高5年OS(47.9% vs 36.1%,P=0.03)和DFS(39% vs 24.2%,P=0.02)显著相关。
  • N2患者中NR<40%与更高5年OS(36.9% vs 21.8%,P<0.001)和DFS(23.9% vs 9.1%,P<0.001)显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The prognostic role of the number of resected and metastatic lymph nodes in non-small-cell lung cancer (NSCLC) is still being debated. The aim of this study was to evaluate the impact of lymphadenectomy in addition to the already validated variables in NSCLC survival. METHODS: From January 2002 to December 2012, data on 4858 patients with NSCLC undergoing anatomical lung resection and hilomediastinal lymphadenectomy in 6 institutions were analysed retrospectively. Established prognostic factors in addition to the number of resected lymph nodes and the ratio between the number of metastatic lymph nodes and the number of resected lymph nodes (NR) were correlated to overall survival (OS) and disease-free survival (DFS) using the multivariable Cox regression model. Harrell's C-statistic with the 95% confidence interval (CI) was determined. Analysis by means of maximally selected log-rank statistics was performed to find optimal cut-off points in order to split patients into groups with different outcome probabilities. RESULTS: The median numbers of resected lymph nodes and of metastatic lymph nodes were 17 (range 6-85) and 2 (1-36), respectively. Hilar (N1) and mediastinal (N2) metastases were identified in 21.3% and 20.0% of cases, respectively. Overall, the 5-year OS and DFS rates were 54.6% and 44.8%, respectively. At multivariable analysis, age, gender, pathological stage, R0 resection, type of surgery and NR correlated with longer OS rates; the same variables plus tumour grading were further related to DFS. C-statistics were 66.0 (95% CI 62.7-69.4) for DFS and 60.5 (95% CI 58.3-62.6) for OS. An NR <40% significantly correlated with a higher 5-year survival rate in the total sample (OS 57.6% vs 23.8%, P < 0.001; DFS 48.2% vs 11.4, P < 0.001) and in patients with N1 (OS 47.9% vs 36.1%, P = 0.03; DFS 39% vs 24.2%, P = 0.02) and N2 (OS 36.9% vs 21.8%, P < 0.001 DFS 23.9% vs 9.1%, P < 0.001). CONCLUSIONS: Our study confirms that the number of resected lymph nodes is a strong prognostic indicator in NSCLC. In particular, an NR cut-off value of 40% may predict both OS and DFS.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Chiappetta M, Leuzzi G, Sperduti I, et al. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†. Eur J Cardiothorac Surg. 2019. PMID: 30202953. doi:10.1093/ejcts/ezy311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。